Peter Tombros

Peter Tombros is professor and distinguished executive-in-residence at the Eberly College of Science, Penn State. He serves and has served on the boards of Cambrex Inc., Penn State Health Milton S. Hershey Medical Center and the Columbia University Medical Center Board of Advisors. Tombros was also appointed to the Commonwealth of Pennsylvania CURE Program, Health Research Advisory Committee, and served as a director of other public companies, including Alpharma, Pharmanet Development Group Inc., Dendrite International and NPS Pharmaceuticals.

Tombros and his wife, Ann, created the Tombros Foundation to pursue their philanthropic interests. He served as chair of the seven-and-one-half-year Pennsylvania State University $2.2 billion Capital Campaign.

Tombros’ professional career includes president and CEO of Enzon Pharma, where Enzon was able to grow from a market capitalization of $44 million to more than $3 billion under his leadership, making Enzon one of the top 20 biotech firms in the United States at that time. Prior to that, he spent 25 years at Pfizer Inc., where he helped build the pharmaceutical business in a variety of positions, including vice president of marketing, senior vice president and general manager and executive vice president of Pfizer Pharmaceuticals. He was also appointed corporate vice president for strategic planning. In that role, he helped Pfizer narrow its focus on health care and oversaw the divestiture of non-health care businesses. Tombros also had oversight for the venture capital firms Pfizer funded to look for new technologies.

Tombros’ private company experience included serving as CEO and director of VivoQuest. The Financial Times selected him to receive its 2015 Outstanding Director Award.

Tombros earned both Master of Science and Bachelor of Arts degrees from Penn State, followed by a Master of Business Administration from the Wharton School at the University of Pennsylvania.